Evidence map›Paper›PMID 28484033›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma.

Artyom A Alekseyenko, Erica M Walsh, Barry M Zee, Tibor Pakozdi, Peter Hsi, Madeleine E Lemieux, Paola Dal Cin, Tan A Ince, Peter V Kharchenko, Mitzi I Kuroda and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Shared PRAME epitopes are T-cell targets in NUT carcinoma.Journal for immunotherapy of cancer · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Clinical analysis and treatment progress of NUT carcinoma in the nasal cavity and sinuses: a retrospective study from a single institution.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Article
  17. [Research Progress on Pathogenesis and Treatment of NUT Carcinoma].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2024
    Review
  18. [NUT cancer of nasal cavity and sinuses: a case report and literature review].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Review
  19. Review
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Artyom A AlekseyenkoDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Erica M WalshDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Barry M ZeeDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Tibor PakozdiDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA 02115.
Peter HsiDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Madeleine E LemieuxBioinfo, Plantagenet, ON, Canada K0B 1L0.ORCID 0000-0001-6355-8691
Paola Dal CinDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Tan A InceDepartment of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136.
Peter V KharchenkoDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA 02115.
Mitzi I KurodaDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; mkuroda@genetics.med.harvard.edu cfrench@partners.org.
Christopher A FrenchDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; mkuroda@genetics.med.harvard.edu cfrench@partners.org.
Brigham and Women's Hospital · USHarvard University · USUniversity of Miami · US

Funding

Pathogenesis of NUT-Rearranged CarcinomaR01CA124633 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Christopher A French · 2007 to 2026
$7.0M
Comprehensive analysis of epigenetic regulators in their native chromatin contextR01GM101958 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KURODA, MITZI I · 2012 to 2018
$2.4M
NCI NIH HHS R01 CA124633NIGMS NIH HHS R01 GM101958
6 · The paper itself

Abstract

To investigate the mechanism that drives dramatic mistargeting of active chromatin in NUT midline carcinoma (NMC), we have identified protein interactions unique to the BRD4-NUT fusion oncoprotein compared with wild-type BRD4. Using cross-linking, affinity purification, and mass spectrometry, we identified the EP300 acetyltransferase as uniquely associated with BRD4 through the NUT fusion in both NMC and non-NMC cell types. We also discovered ZNF532 associated with BRD4-NUT in NMC patient cells but not detectable in 293T cells. EP300 and ZNF532 are both implicated in feed-forward regulatory loops leading to propagation of the oncogenic chromatin complex in BRD4-NUT patient cells. Adding key functional significance to our biochemical findings, we independently discovered a

Indexed as

Bromodomain Containing ProteinsCarcinoma, Squamous CellCell Cycle ProteinsCell Line, TumorCell ProliferationChromatinE1A-Associated p300 ProteinEpithelial CellsFemaleHEK293 CellsHumansIn Situ Hybridization, FluorescenceLung NeoplasmsMiddle AgedMultiprotein ComplexesNeoplasm ProteinsBRD4 protein, humanBromodomain Containing ProteinsCell Cycle ProteinsChromatinE1A-Associated p300 ProteinEP300 protein, humanMultiprotein ComplexesNeoplasm ProteinsNuclear ProteinsNUTM1 protein, humanOncogene ProteinsOncogene Proteins, FusionRepressor ProteinsRNA, Small InterferingTranscription FactorsZNF385B protein, humanBioTAP-XLBRD4hyperacetylationtopological domainsZNF532–NUT

Identifiers

PMID28484033
PMCPMC5448232
OpenAlexW2612477391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.